1-4 of 4
Ranjini Sundaram
Close
Sort by
Journal Articles

PARP Inhibitors Are Effective in IDH1/2 Mutant MDS and AML Resistant to Targeted IDH Inhibitors

Rana Gbyli, MS, Yuanbin Song, MD, Wei Liu, PhD, Yimeng Gao, PhD, Namrata S Chandhok, MD, Xiaoying Fu, MD, Xiaman Wang, MD PhD, Amisha Patel, MS, Ranjini Sundaram, PhD, Toma Tebaldi, PhD, Giulia Biancon, PhD, Anastasia Ardasheva, BS, Ashley Qin, Mukhtar Sadykov, MD, Padmavathi Mamillapalli, BS, Richard Flavell, PhD, Thomas Prebet, MD PhD, Ranjit Bindra, MD PhD, Stephanie Halene, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4222.
https://doi.org/10.1182/blood-2019-130814
Published: 2019
Journal Articles

Prospective analysis of antigen-specific immunity, stem-cell antigens, and immune checkpoints in monoclonal gammopathy

Brief Report
Madhav V. Dhodapkar, Rachael Sexton, Rituparna Das, Kavita M. Dhodapkar, Lin Zhang, Ranjini Sundaram, Sonal Soni, John J. Crowley, Robert Z. Orlowski, Bart Barlogie
Journal: Blood
Blood (2015) 126 (22): 2475–2478.
https://doi.org/10.1182/blood-2015-03-632919
Published: 2015
Includes: Supplemental data
Journal Articles

Clinical regressions and broad immune activation following combination therapy targeting human NKT cells in myeloma

Clinical Trials & Observations
Joshua Richter, Natalia Neparidze, Lin Zhang, Shiny Nair, Tamara Monesmith, Ranjini Sundaram, Fred Miesowicz, Kavita M. Dhodapkar, Madhav V. Dhodapkar
Journal: Blood
Blood (2013) 121 (3): 423–430.
https://doi.org/10.1182/blood-2012-06-435503
Published: 2013
Journal Articles

Dendritic cell–mediated activation-induced cytidine deaminase (AID)–dependent induction of genomic instability in human myeloma

Srinivas Koduru, Ellice Wong, Till Strowig, Ranjini Sundaram, Lin Zhang, Matthew P. Strout, Richard A. Flavell, David G. Schatz, Kavita M. Dhodapkar, Madhav V. Dhodapkar
Journal: Blood
Blood (2012) 119 (10): 2302–2309.
https://doi.org/10.1182/blood-2011-08-376236
Published: 2012